Beijing Hotgen Biotech Co Ltd Asset Resilience Ratio

Latest as of September 2025: 20.87%

Beijing Hotgen Biotech Co Ltd asset resilience ratio. Beijing Hotgen Biotech Co Ltd (688068) has an Asset Resilience Ratio of 20.87% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Hotgen Biotech Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥669.32 Million

≈ $97.94 Million USD Cash + Short-term Investments

Total Assets

CN¥3.21 Billion

≈ $469.40 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Beijing Hotgen Biotech Co Ltd (2021–2024)

Asset resilience ratio of Beijing Hotgen Biotech Co Ltd from 2021 to 2024. This chart shows how Beijing Hotgen Biotech Co Ltd's Asset Resilience Ratio has changed over time. Read 688068 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Beijing Hotgen Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Beijing Hotgen Biotech Co Ltd asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥669.32 Million	20.87%
Total Liquid Assets	CN¥669.32 Million	20.87%

Asset Resilience Insights

Good Liquidity Position: Beijing Hotgen Biotech Co Ltd maintains a healthy 20.87% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Beijing Hotgen Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Hotgen Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Beijing Hotgen Biotech Co Ltd Asset Resilience Ratio by Year (2021–2024)

Beijing Hotgen Biotech Co Ltd asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for Beijing Hotgen Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	6.06%	CN¥201.51 Million ≈ $29.49 Million	CN¥3.33 Billion ≈ $486.68 Million	-1.81pp
2023-12-31	7.86%	CN¥280.02 Million ≈ $40.98 Million	CN¥3.56 Billion ≈ $521.03 Million	-14.93pp
2022-12-31	22.79%	CN¥888.68 Million ≈ $130.04 Million	CN¥3.90 Billion ≈ $570.59 Million	-2.65pp
2021-12-31	25.45%	CN¥927.45 Million ≈ $135.71 Million	CN¥3.64 Billion ≈ $533.36 Million	--

pp = percentage points

About Beijing Hotgen Biotech Co Ltd

SHG:688068 China Biotechnology

Market Cap

$941.62 Million

CN¥6.43 Billion CNY

Market Cap Rank

#8838 Global

#2102 in China

Share Price

CN¥69.41

Change (1 day)

-3.82%

52-Week Range

CN¥64.75 - CN¥205.95

All Time High

CN¥250.80